<p>Trexquant Investment LP 在最近向美国证券交易委员会提交的 13F 文件中表示，在第一季度将其在 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免费报告) 的持股减少了 54.5%。该基金在此期间出售了 262,607 股后，持有该公司 219,000 股股票。Trexquant Investment LP 在最近的报告期末持有的 Hims &amp; Hers Health 的股份约占 0.10%，价值 6,471,000 美元。</p>
<p>获取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
<ul>
<li>Ozempic 热潮：Hims 和 Eli Lilly 引领医疗保健投资</li>
</ul>
<p>其他几家机构投资者和对冲基金最近也对 HIMS 的持仓进行了调整。Farallon Capital Management LLC 在第四季度将其在 Hims &amp; Hers Health 的持仓提高了 64,338.5%。Farallon Capital Management LLC 目前持有该公司 8,377,000 股股票，价值 202,556,000 美元，此前在上个季度又增持了 8,364,000 股。Nuveen LLC 在第一季度购买了 Hims &amp; Hers Health 的新股份，价值 58,403,000 美元。Yong Rong HK Asset Management Ltd 在第一季度将其在 Hims &amp; Hers Health 的持仓提高了 41.2%。Yong Rong HK Asset Management Ltd 目前持有该公司 2,400,000 股股票，价值 70,920,000 美元，此前在上个季度又增持了 700,100 股。CloudAlpha Capital Management Limited Hong Kong 在第一季度购买了 Hims &amp; Hers Health 的新股份，价值 20,580,000 美元。最后，Jump Financial LLC 在第一季度将其在 Hims &amp; Hers Health 的持仓提高了 633.2%。Jump Financial LLC 目前持有该公司 725,445 股股票，价值 21,437,000 美元，此前在上个季度又增持了 626,496 股。机构投资者目前持有该公司 63.52% 的股份。</p>
<h2>华尔街分析师观点</h2>
<p>几位分析师对该股票发表了评论。Wall Street Zen 在 7 月 28 日的研究报告中将 Hims &amp; Hers Health 的股票评级从 &#34;买入&#34; 下调至 &#34;持有&#34;。Zacks Research 在 8 月 19 日的研究报告中将 Hims &amp; Hers Health 的股票评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。瑞银集团在 6 月 23 日的报告中对 Hims &amp; Hers Health 的股票设定了 30.00 美元的目标价。Piper Sandler 在 5 月 6 日的报告中重申了 &#34;中性&#34; 的评级，并将 Hims &amp; Hers Health 的目标价上调至 39.00 美元（之前为 35.00 美元）。最后，Needham &amp; Company LLC 在 8 月 5 日的报告中重申了 Hims &amp; Hers Health 的 &#34;持有&#34; 评级。两位投资分析师对该股票给予了买入评级，八位分析师给予了持有评级，三位分析师给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 &#34;减持&#34;，平均目标价为 38.92 美元。</p>
<ul>
<li>内部人士在与 NVIDIA 相关的 Navitas、Hims 和 Shift4 中交易数百万</li>
</ul>
<p><strong>查看我们关于 HIMS 的最新报告</strong></p>
<h2>Hims &amp; Hers Health 价格表现</h2>
<p>HIMS 股票在周五开盘价为 42.36 美元。Hims &amp; Hers Health, Inc. 的 12 个月低点为 13.47 美元，12 个月高点为 72.98 美元。该公司的市值为 95.7 亿美元，市盈率为 52.95，市盈增长比率为 2.86，贝塔系数为 2.08。该公司的速动比率为 4.46，流动比率为 4.98，债务股本比率为 1.72。该公司的 50 日移动平均线为 49.98 美元，200 日移动平均线为 45.82 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 08/04 - 08/08</li>
</ul>
<p>Hims &amp; Hers Health (NYSE:HIMS - 获取免费报告) 最近在 8 月 4 日星期一公布了季度财报。该公司报告每股收益 (EPS) 为 0.17 美元，低于市场共识预期的 0.18 美元，差额为 0.01 美元。该公司在本季度的收入为 5.4483 亿美元，而分析师预期为 5.5006 亿美元。Hims &amp; Hers Health 的净利润率为 9.63%，股本回报率为 26.26%。Hims &amp; Hers Health 的季度收入同比增长 72.6%。去年同期，该公司每股收益为 0.06 美元。Hims &amp; Hers Health 已设定 2025 年第三季度的每股收益指导。2025 财年的每股收益指导。平均而言，股票研究分析师预测 Hims &amp; Hers Health, Inc. 今年将发布 0.29 美元的每股收益。</p>
<h2>Hims &amp; Hers Health 的内部活动</h2>
<p>在相关消息中，内部人士 Patrick Harrison Carroll 于 8 月 6 日星期三出售了 60,000 股该公司的股票。股票以平均价格 53.58 美元出售，总价值为 3,214,800.00 美元。交易完成后，该内部人士直接持有该公司 169,940 股股票，价值约 9,105,385.20 美元。这代表其持股减少了 26.09%。该交易在向证券交易委员会提交的文件中披露，文件可通过此链接访问。此外，首席执行官 Andrew Dudum 于 8 月 7 日星期四出售了 660,000 股该公司的股票。股票以平均价格 50.58 美元出售，总交易额为 33,382,800.00 美元。交易完成后，首席执行官直接持有该公司 2,214,769 股股票，价值约 112,023,016.02 美元。该交易使其持股减少了 22.96%。该交易的披露信息可以在这里找到。内部人士在上个季度共出售了 1,395,428 股公司股票，价值 71,753,898 美元。当前公司内部人士持有 13.71% 的股份。</p>
<h2>Hims &amp; Hers Health 概况</h2>
<p>(免费报告)</p>
<p>Hims &amp; Hers Health, Inc. 运营一个远程医疗咨询平台。它将消费者与医疗专业人员连接，使他们能够获得心理健康、性健康、皮肤病和初级护理的医疗服务。该公司成立于 2017 年，总部位于加利福尼亚州旧金山。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票，而不是 Hims &amp; Hers Health</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>DICKS 体育用品公司的股票在财报发布后下跌——这是一只值得购买的股票吗？</li>
<li>如何知道一只股票是否支付股息以及何时支付</li>
<li>AI 引擎：康明斯意外的增长驱动因素</li>
<li>除息日对投资者的重要性是什么？</li>
<li>小型工业公司正在经历快速增长：原因在这里</li>
</ul>
<p><strong>想看看其他对 HIMS 感兴趣的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Hims &amp; Hers Health 吗？</h2>
<p>在考虑 Hims &amp; Hers Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 Hims &amp; Hers Health 并不在名单上。</p>
<p>虽然 Hims &amp; Hers Health 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HIMS

<p>Trexquant Investment LP 已将其在 Hims & Hers Health, Inc. 的持股比例减少了 54.5%，出售了 262,607 股，目前持有 219,000 股。该基金的持股价值约为 647 万美元。其他机构投资者也调整了他们的持仓，其中 Farallon Capital Management 和 Jump Financial 的增持幅度显著。分析师对 Hims & Hers Health 的评级意见不一，普遍评级为 “减持”，平均目标价为 38.92 美元。该股票开盘价为 42.36 美元，12 个月的价格区间为 13.47 美元至 72.98 美元</p>

<p>Trexquant Investment LP decreased its holdings in shares of Hims &amp; Hers Health, Inc. (NYSE:HIMS - Free Report) by 54.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 219,000 shares of the company's stock after selling 262,607 shares during the period. Trexquant Investment LP owned approximately 0.10% of Hims &amp; Hers Health worth $6,471,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Trexquant Investment LP 在最近向美国证券交易委员会提交的 13F 文件中表示，在第一季度将其在 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免费报告) 的持股减少了 54.5%。该基金在此期间出售了 262,607 股后，持有该公司 219,000 股股票。Trexquant Investment LP 在最近的报告期末持有的 Hims &amp; Hers Health 的股份约占 0.10%，价值 6,471,000 美元。</p>
</div><p>Get <strong>Hims &amp; Hers Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
</div><ul>
<li>Ozempic Boom: Hims &amp; Eli Lilly Lead Healthcare Bets</li>
</ul>
<div class="lb-trans"><ul>
<li>Ozempic 热潮：Hims 和 Eli Lilly 引领医疗保健投资</li>
</ul>
</div><p>Several other institutional investors and hedge funds also recently made changes to their positions in HIMS. Farallon Capital Management LLC raised its position in shares of Hims &amp; Hers Health by 64,338.5% during the 4th quarter. Farallon Capital Management LLC now owns 8,377,000 shares of the company's stock valued at $202,556,000 after acquiring an additional 8,364,000 shares during the last quarter. Nuveen LLC bought a new stake in shares of Hims &amp; Hers Health during the 1st quarter valued at $58,403,000. Yong Rong HK Asset Management Ltd raised its position in shares of Hims &amp; Hers Health by 41.2% during the 1st quarter. Yong Rong HK Asset Management Ltd now owns 2,400,000 shares of the company's stock valued at $70,920,000 after acquiring an additional 700,100 shares during the last quarter. CloudAlpha Capital Management Limited Hong Kong bought a new stake in shares of Hims &amp; Hers Health during the 1st quarter valued at $20,580,000. Finally, Jump Financial LLC raised its position in shares of Hims &amp; Hers Health by 633.2% during the 1st quarter. Jump Financial LLC now owns 725,445 shares of the company's stock valued at $21,437,000 after acquiring an additional 626,496 shares during the last quarter. Institutional investors own 63.52% of the company's stock.</p>
<div class="lb-trans"><p>其他几家机构投资者和对冲基金最近也对 HIMS 的持仓进行了调整。Farallon Capital Management LLC 在第四季度将其在 Hims &amp; Hers Health 的持仓提高了 64,338.5%。Farallon Capital Management LLC 目前持有该公司 8,377,000 股股票，价值 202,556,000 美元，此前在上个季度又增持了 8,364,000 股。Nuveen LLC 在第一季度购买了 Hims &amp; Hers Health 的新股份，价值 58,403,000 美元。Yong Rong HK Asset Management Ltd 在第一季度将其在 Hims &amp; Hers Health 的持仓提高了 41.2%。Yong Rong HK Asset Management Ltd 目前持有该公司 2,400,000 股股票，价值 70,920,000 美元，此前在上个季度又增持了 700,100 股。CloudAlpha Capital Management Limited Hong Kong 在第一季度购买了 Hims &amp; Hers Health 的新股份，价值 20,580,000 美元。最后，Jump Financial LLC 在第一季度将其在 Hims &amp; Hers Health 的持仓提高了 633.2%。Jump Financial LLC 目前持有该公司 725,445 股股票，价值 21,437,000 美元，此前在上个季度又增持了 626,496 股。机构投资者目前持有该公司 63.52% 的股份。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several analysts have commented on the stock. Wall Street Zen cut shares of Hims &amp; Hers Health from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, July 28th. Zacks Research cut shares of Hims &amp; Hers Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, August 19th. UBS Group set a $30.00 price target on shares of Hims &amp; Hers Health in a report on Monday, June 23rd. Piper Sandler reissued a &#34;neutral&#34; rating and issued a $39.00 price target (up previously from $35.00) on shares of Hims &amp; Hers Health in a report on Tuesday, May 6th. Finally, Needham &amp; Company LLC reissued a &#34;hold&#34; rating on shares of Hims &amp; Hers Health in a report on Tuesday, August 5th. Two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of &#34;Reduce&#34; and an average price target of $38.92.</p>
<div class="lb-trans"><p>几位分析师对该股票发表了评论。Wall Street Zen 在 7 月 28 日的研究报告中将 Hims &amp; Hers Health 的股票评级从 &#34;买入&#34; 下调至 &#34;持有&#34;。Zacks Research 在 8 月 19 日的研究报告中将 Hims &amp; Hers Health 的股票评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。瑞银集团在 6 月 23 日的报告中对 Hims &amp; Hers Health 的股票设定了 30.00 美元的目标价。Piper Sandler 在 5 月 6 日的报告中重申了 &#34;中性&#34; 的评级，并将 Hims &amp; Hers Health 的目标价上调至 39.00 美元（之前为 35.00 美元）。最后，Needham &amp; Company LLC 在 8 月 5 日的报告中重申了 Hims &amp; Hers Health 的 &#34;持有&#34; 评级。两位投资分析师对该股票给予了买入评级，八位分析师给予了持有评级，三位分析师给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 &#34;减持&#34;，平均目标价为 38.92 美元。</p>
</div><ul>
<li>Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, &amp; Shift4</li>
</ul>
<div class="lb-trans"><ul>
<li>内部人士在与 NVIDIA 相关的 Navitas、Hims 和 Shift4 中交易数百万</li>
</ul>
</div><p><strong>Check Out Our Latest Report on HIMS</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 HIMS 的最新报告</strong></p>
</div><h2>Hims &amp; Hers Health Price Performance</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 价格表现</h2>
</div><p>Shares of HIMS stock opened at $42.36 on Friday. Hims &amp; Hers Health, Inc. has a 12-month low of $13.47 and a 12-month high of $72.98. The firm has a market capitalization of $9.57 billion, a price-to-earnings ratio of 52.95, a price-to-earnings-growth ratio of 2.86 and a beta of 2.08. The company has a quick ratio of 4.46, a current ratio of 4.98 and a debt-to-equity ratio of 1.72. The firm has a fifty day moving average of $49.98 and a 200-day moving average of $45.82.</p>
<div class="lb-trans"><p>HIMS 股票在周五开盘价为 42.36 美元。Hims &amp; Hers Health, Inc. 的 12 个月低点为 13.47 美元，12 个月高点为 72.98 美元。该公司的市值为 95.7 亿美元，市盈率为 52.95，市盈增长比率为 2.86，贝塔系数为 2.08。该公司的速动比率为 4.46，流动比率为 4.98，债务股本比率为 1.72。该公司的 50 日移动平均线为 49.98 美元，200 日移动平均线为 45.82 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/04 - 08/08</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/04 - 08/08</li>
</ul>
</div><p>Hims &amp; Hers Health (NYSE:HIMS - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $544.83 million during the quarter, compared to analyst estimates of $550.06 million. Hims &amp; Hers Health had a net margin of 9.63% and a return on equity of 26.26%. Hims &amp; Hers Health's quarterly revenue was up 72.6% on a year-over-year basis. During the same period last year, the firm earned $0.06 EPS. Hims &amp; Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts forecast that Hims &amp; Hers Health, Inc. will post 0.29 earnings per share for the current year.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health (NYSE:HIMS - 获取免费报告) 最近在 8 月 4 日星期一公布了季度财报。该公司报告每股收益 (EPS) 为 0.17 美元，低于市场共识预期的 0.18 美元，差额为 0.01 美元。该公司在本季度的收入为 5.4483 亿美元，而分析师预期为 5.5006 亿美元。Hims &amp; Hers Health 的净利润率为 9.63%，股本回报率为 26.26%。Hims &amp; Hers Health 的季度收入同比增长 72.6%。去年同期，该公司每股收益为 0.06 美元。Hims &amp; Hers Health 已设定 2025 年第三季度的每股收益指导。2025 财年的每股收益指导。平均而言，股票研究分析师预测 Hims &amp; Hers Health, Inc. 今年将发布 0.29 美元的每股收益。</p>
</div><h2>Insider Activity at Hims &amp; Hers Health</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 的内部活动</h2>
</div><p>In related news, insider Patrick Harrison Carroll sold 60,000 shares of the company's stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $53.58, for a total value of $3,214,800.00. Following the completion of the transaction, the insider directly owned 169,940 shares of the company's stock, valued at approximately $9,105,385.20. This represents a 26.09% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Also, CEO Andrew Dudum sold 660,000 shares of the company's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $50.58, for a total transaction of $33,382,800.00. Following the completion of the transaction, the chief executive officer directly owned 2,214,769 shares of the company's stock, valued at approximately $112,023,016.02. The trade was a 22.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,395,428 shares of company stock valued at $71,753,898 in the last quarter. 13.71% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，内部人士 Patrick Harrison Carroll 于 8 月 6 日星期三出售了 60,000 股该公司的股票。股票以平均价格 53.58 美元出售，总价值为 3,214,800.00 美元。交易完成后，该内部人士直接持有该公司 169,940 股股票，价值约 9,105,385.20 美元。这代表其持股减少了 26.09%。该交易在向证券交易委员会提交的文件中披露，文件可通过此链接访问。此外，首席执行官 Andrew Dudum 于 8 月 7 日星期四出售了 660,000 股该公司的股票。股票以平均价格 50.58 美元出售，总交易额为 33,382,800.00 美元。交易完成后，首席执行官直接持有该公司 2,214,769 股股票，价值约 112,023,016.02 美元。该交易使其持股减少了 22.96%。该交易的披露信息可以在这里找到。内部人士在上个季度共出售了 1,395,428 股公司股票，价值 71,753,898 美元。当前公司内部人士持有 13.71% 的股份。</p>
</div><h2>Hims &amp; Hers Health Profile</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 概况</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Hims &amp; Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health, Inc. 运营一个远程医疗咨询平台。它将消费者与医疗专业人员连接，使他们能够获得心理健康、性健康、皮肤病和初级护理的医疗服务。该公司成立于 2017 年，总部位于加利福尼亚州旧金山。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Hims &amp; Hers Health</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?</li>
<li>How to Know if a Stock Pays Dividends and When They Are Paid Out</li>
<li>Engines to AI: Cummins’ Surprising Growth Driver</li>
<li>Why is the Ex-Dividend Date Significant to Investors?</li>
<li>Smaller Industrials Names Seeing Surging Growth: Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Hims &amp; Hers Health</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>DICKS 体育用品公司的股票在财报发布后下跌——这是一只值得购买的股票吗？</li>
<li>如何知道一只股票是否支付股息以及何时支付</li>
<li>AI 引擎：康明斯意外的增长驱动因素</li>
<li>除息日对投资者的重要性是什么？</li>
<li>小型工业公司正在经历快速增长：原因在这里</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HIMS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hims &amp; Hers Health, Inc. (NYSE:HIMS - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 HIMS 感兴趣的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HIMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Hims &amp; Hers Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Hims &amp; Hers Health 吗？</h2>
</div><p>Before you consider Hims &amp; Hers Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Hims &amp; Hers Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims &amp; Hers Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 Hims &amp; Hers Health 并不在名单上。</p>
</div><p>While Hims &amp; Hers Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Hims &amp; Hers Health 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Trexquant Investment LP 出售了 262,607 股 Hims & Hers Health, Inc.的股票，股票代码为$HIMS